EU Authorised Representative for Medical Devices & IVDs is a practical guide explaining MDR and IVDR compliance, EU regulatory requirements, technical documentation, and market access. It helps manufacturers understand how to legally sell medical devices in the EU and UK with proper registration and compliance support.
If you’re planning to sell medical devices in the EU, the process usually feels straightforward at first—get CE marking, prepare documentation, and assume you’re ready.
But the reality is different once MDR and IVDR come into play.
The European market doesn’t just regulate the product. It regulates responsibility. And for companies outside the EU, that responsibility must sit with someone inside the region. That’s where the EU Authorised Representative comes in.
Without it, even a fully compliant device can get blocked from market entry or delayed during registration.
Think of it less like a service provider and more like a legal extension of your company inside the EU.
An EU Authorised Representative is an EU-based entity that acts on behalf of non-EU manufacturers. Its job is not only to “assist” but to officially represent the manufacturer in front of regulators.
So when EU authorities need technical files, clarification, or compliance confirmation, they don’t reach the manufacturer directly—they go through the authorised representative.
It becomes the official compliance bridge between your business and the EU regulatory system.
Most manufacturers only realize the importance of this role when they face delays.
The EU system is built on traceability and accountability. If something goes wrong with a device—whether it’s a safety concern or a documentation issue—there must be a responsible entity inside the EU who can respond quickly.
Without an authorised representative, that chain breaks.
In practical terms, this can lead to:
So even if your product is technically strong, missing this role can stop market access completely.
EU medical device compliance is not one single approval step. It’s more like a layered verification system.
First, the technical documentation is reviewed. This includes design details, manufacturing processes, risk files, and performance evidence. Everything must align with MDR Annex II & III or IVDR requirements depending on the device.
Then comes risk management. This is where ISO 14971 is applied, and every possible hazard is documented along with control measures. Regulators want to see not just safety claims, but how those claims are proven.
After that, registration happens through systems like EUDAMED in the EU or MHRA for UK access. This is where traceability is officially created.
Even packaging and labeling are not secondary—they are checked in detail, including symbols, language versions, and manufacturer information.
In practice, most delays happen not because of product issues, but because documentation is incomplete or inconsistent.
This requirement applies before your product enters the EU market, not after.
You need one if:
Waiting until the end of the process usually creates unnecessary rework. It’s better handled at the planning stage itself.
It’s not only large manufacturers. In fact, most clients fall into mid-size or growing businesses trying to enter Europe for the first time.
This includes diagnostic kit manufacturers, OEM suppliers, private label brands, and distributors expanding their product range into EU markets.
The common challenge is always the same—documentation complexity increases faster than expected.
There is no universal method here. It depends on how many products you are launching and how complex they are.
A single-device company usually follows a simpler MDR route with basic support from an authorised representative.
But companies with multiple devices usually benefit from a full documentation review first, before any submission happens. It avoids rejection cycles later.
If you are targeting both the EU and UK markets, planning them together is important because the regulatory pathways are different and cannot be merged.
Complico Consulting works specifically in regulatory compliance for medical devices and IVDs entering EU and UK markets.
What matters here is not just registration support, but the structure behind it—technical file review, compliance gap identification, labeling checks, and ongoing regulatory support after market entry.
For many manufacturers, the value is in avoiding rework and regulatory rejection rather than just completing paperwork.
An EU Authorised Representative is an EU-based legal entity that represents non-EU medical device manufacturers under MDR and IVDR rules. It manages regulatory communication, technical documentation access, and registration to ensure legal access to the European market.
EU medical device compliance is not just about approval—it is about maintaining a legal structure that supports continuous accountability.
The EU Authorised Representative is a core part of that structure for any non-EU manufacturer entering the market.
Without it, even compliant products face barriers that are purely regulatory, not technical.
For structured support in this process, Complico Consulting provides end-to-end MDR and IVDR compliance assistance.
